PPA
VIVO

Parametric Portfolio Associates’s Meridian Bioscience Inc VIVO Stock Holding History

Parametric Portfolio Associates’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$3.3M Buy
127,017
+29,193
+30% +$694K ﹤0.01% 2126
2021
Q4 		$2M Sell
97,824
-18,047
-16% -$346K ﹤0.01% 2436
2021
Q3 		$2.23M Sell
115,871
-1,877
-2% -$37.4K ﹤0.01% 2387
2021
Q2 		$2.61M Sell
117,748
-45,708
-28% -$970K ﹤0.01% 2286
2021
Q1 		$4.29M Sell
163,456
-17,399
-10% -$414K ﹤0.01% 2288
2020
Q4 		$3.38M Buy
180,855
+23,310
+15% +$435K ﹤0.01% 2334
2020
Q3 		$2.67M Sell
157,545
-29,132
-16% -$566K ﹤0.01% 2319
2020
Q2 		$4.35M Buy
186,677
+62,339
+50% +$903K ﹤0.01% 1970
2020
Q1 		$1.04M Sell
124,338
-33,980
-21% -$286K ﹤0.01% 2776
2019
Q4 		$1.55M Buy
158,318
+35,910
+29% +$337K ﹤0.01% 2845
2019
Q3 		$1.16M Sell
122,408
-48,075
-28% -$507K ﹤0.01% 2947
2019
Q2 		$2.02M Sell
170,483
-192,479
-53% -$2.32M ﹤0.01% 2667
2019
Q1 		$6.39M Buy
362,962
+9,982
+3% +$166K 0.01% 1783
2018
Q4 		$6.13M Sell
352,980
-90,630
-20% -$1.55M 0.01% 1721
2018
Q3 		$6.61M Buy
443,610
+81,818
+23% +$1.27M 0.01% 1785
2018
Q2 		$5.75M Buy
361,792
+57,450
+19% +$857K 0.01% 1841
2018
Q1 		$4.32M Buy
304,342
+86,446
+40% +$1.28M ﹤0.01% 2021
2017
Q4 		$3.05M Buy
217,896
+25,708
+13% +$376K ﹤0.01% 2296
2017
Q3 		$2.75M Buy
192,188
+3,024
+2% +$43.2K ﹤0.01% 2356
2017
Q2 		$2.98M Buy
189,164
+28,888
+18% +$416K ﹤0.01% 2225
2017
Q1 		$2.21M Buy
160,276
+75,535
+89% +$1.06M ﹤0.01% 2379
2016
Q4 		$1.5M Buy
84,741
+1,912
+2% +$33.6K ﹤0.01% 2576
2016
Q3 		$1.6M Sell
82,829
-36,320
-30% -$711K ﹤0.01% 2499
2016
Q2 		$2.32M Buy
119,149
+2,210
+2% +$43.3K ﹤0.01% 2215
2016
Q1 		$2.41M Buy
116,939
+39,258
+51% +$774K ﹤0.01% 2248
2015
Q4 		$1.59M Buy
77,681
+5,501
+8% +$105K ﹤0.01% 2417
2015
Q3 		$1.23M Buy
72,180
+6,400
+10% +$117K ﹤0.01% 2186
2015
Q2 		$1.23M Sell
65,780
-732
-1% -$13.6K ﹤0.01% 2645
2015
Q1 		$1.27M Buy
66,512
+12,997
+24% +$240K ﹤0.01% 2606
2014
Q4 		$881K Buy
53,515
+4,028
+8% +$69.1K ﹤0.01% 2882
2014
Q3 		$875K Sell
49,487
-815
-2% -$16K ﹤0.01% 2807
2014
Q2 		$1.04M Sell
50,302
-5,453
-10% -$112K ﹤0.01% 2681
2014
Q1 		$1.22M Sell
55,755
-1,337
-2% -$30.6K ﹤0.01% 2509
2013
Q4 		$1.51M Buy
57,092
+956
+2% +$23.5K ﹤0.01% 2295
2013
Q3 		$1.33M Sell
56,136
-739
-1% -$17.3K ﹤0.01% 2320
2013
Q2 		$1.22M Buy
+56,875
New +$1.23M ﹤0.01% 2265

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parametric Portfolio Associates's VIVO Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Meridian Bioscience Inc (VIVO) stake by 30% in Q1 2022, buying an estimated $694K and bringing the position to 127,017 shares worth $3.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2126.

Parametric Portfolio Associates first reported a position in VIVO in Q2 2013 and has held it in 36 quarters since. The position peaked at $6.61M in Q3 2018. 210 funds tracked by Wall St. Rank hold VIVO as of Q1 2022.

  • Parametric Portfolio Associates held 127,017 shares of Meridian Bioscience Inc worth $3.3M as of Q1 2022.
  • Parametric Portfolio Associates bought 29,193 Meridian Bioscience Inc shares in Q1 2022, an estimated $694K.
  • Meridian Bioscience Inc made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2126 holding.
  • Parametric Portfolio Associates first reported a position in Meridian Bioscience Inc in Q2 2013 and has held it in 36 quarters since.
  • Parametric Portfolio Associates's Meridian Bioscience Inc position peaked at $6.61M in Q3 2018.
  • 210 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.